Maia Wealth LLC Acquires 1,047 Shares of Elevance Health, Inc. (NYSE:ELV)

Maia Wealth LLC increased its stake in Elevance Health, Inc. (NYSE:ELV) by 19.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,432 shares of the company’s stock after acquiring an additional 1,047 shares during the period. Maia Wealth LLC’s holdings in Elevance Health were worth $2,373,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the stock. Raelipskie Partnership purchased a new position in shares of Elevance Health in the 3rd quarter worth approximately $26,000. Crews Bank & Trust purchased a new stake in Elevance Health during the 4th quarter valued at $34,000. Dunhill Financial LLC lifted its position in Elevance Health by 57.8% in the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after buying an additional 26 shares during the last quarter. Peterson Financial Group Inc. purchased a new position in Elevance Health during the third quarter worth $44,000. Finally, Financial Perspectives Inc bought a new position in Elevance Health during the fourth quarter valued at $50,000. 89.24% of the stock is owned by institutional investors.

Elevance Health Stock Up 1.1 %

NYSE:ELV opened at $397.09 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.45 and a quick ratio of 1.50. Elevance Health, Inc. has a 1-year low of $362.21 and a 1-year high of $567.26. The company has a 50-day moving average of $387.78 and a 200 day moving average of $439.07. The firm has a market cap of $90.28 billion, a PE ratio of 15.51, a price-to-earnings-growth ratio of 1.18 and a beta of 0.83.

Elevance Health (NYSE:ELV) last announced its quarterly earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share for the quarter, topping the consensus estimate of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%. As a group, research analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be issued a $1.71 dividend. The ex-dividend date of this dividend is Monday, March 10th. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.72%. Elevance Health’s dividend payout ratio (DPR) is currently 26.71%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ELV shares. Truist Financial lowered their target price on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company decreased their price objective on shares of Elevance Health from $483.00 to $478.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a research note on Saturday. Mizuho decreased their price target on Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. Finally, Argus restated a “hold” rating and set a $405.40 price objective on shares of Elevance Health in a report on Wednesday, January 29th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Elevance Health currently has an average rating of “Moderate Buy” and a consensus target price of $517.03.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.